(Total Views: 649)
Posted On: 03/04/2022 4:20:33 PM
Post# of 148876
Leronlimab is an investigational drug that has not been approved by the US FDA for the treatment of COVID-19 or for any other indication.
CytoDyn is in the process of updating the company's website to provide current information on the status of our development of leronlimab for the indications for which it is being studied.
CytoDyn website updated. Looks like this is a direct response to the FDA letter.
CytoDyn is in the process of updating the company's website to provide current information on the status of our development of leronlimab for the indications for which it is being studied.
CytoDyn website updated. Looks like this is a direct response to the FDA letter.
(3)
(0)Scroll down for more posts ▼
